Skip to content
PICO Portalanswers from OpenAlex

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

PaperCitations, authors & open-access status

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors is a paper indexed in PICO Portal from OpenAlex.

How many citations does Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors have?

PICO Portalcitation count

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors has 511 citations in the OpenAlex counts PICO Portal stores.

When was Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors published?

PICO Portalyear

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors has 2017 year in the PICO Portal index.

What is the open-access status of Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors?

PICO Portaloa status

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors has bronze oa status in the PICO Portal index.

What is the DOI of Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors?

PICO Portaldoi

The DOI for Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors is on the source record.

What is the PMID of Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors?

PICO Portalpmid

The PMID for Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors is on the source record.

What is the OpenAlex record for Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors?

PICO Portalopenalex

The OpenAlex for Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial